The development of in vivo tracer methods to obtain new information about human disease: A study of the hallucinating brain

T. Jones; D. A. Silbersweig; E. Stern; L. Schnorr; J. Seaward; J. C. Clark; A. A. Lammertsma; S. Grootoonk

doi:10.1007/BF00837633

The development of in vivo tracer methods to obtain new information about human disease: A study of the hallucinating brain

T. Jones
, D. A. Silbersweig
, E. Stern
, L. Schnorr
, J. Seaward
, J. C. Clark
, A. A. Lammertsma
, S. Grootoonk

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.

Original language	English
Pages (from-to)	332-335
Number of pages	4
Journal	European Journal of Nuclear Medicine
Volume	23
Issue number	3
DOIs	https://doi.org/10.1007/BF00837633
State	Published - 1996
Externally published	Yes

Keywords

Hallucinations
In vivo tracer studies
Methodological evolution
Schizophrenia

Access to Document

10.1007/BF00837633

Cite this

@article{8f2260b72c044314b6a47fda35bcab43,

title = "The development of in vivo tracer methods to obtain new information about human disease: A study of the hallucinating brain",

abstract = "An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.",

keywords = "Hallucinations, In vivo tracer studies, Methodological evolution, Schizophrenia",

author = "T. Jones and Silbersweig, \{D. A.\} and E. Stern and L. Schnorr and J. Seaward and Clark, \{J. C.\} and Lammertsma, \{A. A.\} and S. Grootoonk",

year = "1996",

doi = "10.1007/BF00837633",

language = "English",

volume = "23",

pages = "332--335",

journal = "European Journal of Nuclear Medicine",

issn = "0340-6997",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - The development of in vivo tracer methods to obtain new information about human disease

T2 - A study of the hallucinating brain

AU - Jones, T.

AU - Silbersweig, D. A.

AU - Stern, E.

AU - Schnorr, L.

AU - Seaward, J.

AU - Clark, J. C.

AU - Lammertsma, A. A.

AU - Grootoonk, S.

PY - 1996

Y1 - 1996

N2 - An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.

AB - An outline is provided of the development of methodological strategies to address the question of focal cerebral activation during hallucinations in schizophrenic patients. In so doing, the innovation and diligence required to tailor in vivo tracer procedures to specific clinical research issues are highlighted. Attention is drawn to the complexity of methodological advances and the way in which they are based upon close scientific and technical collaboration between clinical scientists, and non-clinical scientists and research support staff.

KW - Hallucinations

KW - In vivo tracer studies

KW - Methodological evolution

KW - Schizophrenia

UR - https://www.scopus.com/pages/publications/0029873526

U2 - 10.1007/BF00837633

DO - 10.1007/BF00837633

M3 - Article

C2 - 8599966

AN - SCOPUS:0029873526

SN - 0340-6997

VL - 23

SP - 332

EP - 335

JO - European Journal of Nuclear Medicine

JF - European Journal of Nuclear Medicine

IS - 3

ER -

The development of in vivo tracer methods to obtain new information about human disease: A study of the hallucinating brain

Abstract

Keywords

Access to Document

Fingerprint

Cite this